Patent suits launched over breakthrough cancer drug

Biopharmalex 2018-08-15 10:25 pm By Miklos Bolza | Sydney

Please login to bookmark

Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au